Document ID: FDA-2012-N-0001-0033
Agency: fda
Document Type: Notice
Title: Preparation for International Cooperation on Cosmetics Regulations: Meetings
Posted Date: 2012-03-09T05:00Z

[Federal Register Volume 77, Number 47 (Friday, March 9, 2012)]
[Notices]
[Page 14405]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5744]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Preparation for International Cooperation on Cosmetics 
Regulations; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting entitled ``International Cooperation on Cosmetics Regulations 
(ICCR)-Preparation for ICCR-6 Meeting in Rockville, Maryland'' to 
provide information and receive comments on the International 
Cooperation on Cosmetics Regulations (ICCR) as well as the upcoming 
meetings in Rockville, MD. The topics to be discussed are the topics 
for discussion at the forthcoming ICCR Steering Committee meeting. The 
purpose of the meeting is to solicit public input prior to the next 
steering committee and expert working group meetings in Rockville, MD 
on July10 to 13, 2012.
    Date and Time: The meeting will be held on May 15, 2012, from 2 to 
4 p.m.
    Location: The meeting will be held in the Washington Theater Room 
at the Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: All participants must register with Kimberly 
Franklin, Office of the Commissioner, Food and Drug Administration, 
10903 New Hampshire Ave., Silver Spring, MD 20993, by email: 
Kimberly.Franklin@fda.hhs.gov or FAX: 301-595-7937.
    Registration and Requests for Oral Presentations: Send registration 
information (including: Name, title, firm name, address, telephone, and 
fax number), written material and requests to make oral presentation, 
to the contact person by May 9, 2012.
    If you need special accommodations due to a disability, please 
contact Kimberly Franklin (see Contact Person) at least 7 days in 
advance.
    Interested persons may present data, information, or views orally 
or in writing, on issues pending at the public meeting. Time allotted 
for oral presentations may be limited to 10 minutes. Those desiring to 
make oral presentations should notify the contact person by May 9, 
2012, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses, 
telephone number, FAX and email of the proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Transcripts: Please be advised that as soon as a transcript is 
available, it will be accessible at http://www.regulations.gov. It may 
be viewed at the Division of Dockets Management (HFA-305), Food and 
Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A 
transcript will also be available in either hardcopy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information (ELEM-1029), Food 
and Drug Administration, 12420 Parklawn Dr., Element Bldg. Rockville, 
MD 20857.

SUPPLEMENTARY INFORMATION: The purpose of the multilateral framework on 
the ICCR is to pave the way for the removal of regulatory obstacles to 
international trade while maintaining global consumer protection.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from the: United States, Japan, the European Union, and 
Canada. These regulatory authority members will enter into constructive 
dialogue with their relevant cosmetics' industry trade associations. 
Currently, the ICCR members are: Health Canada; the European 
Directorate General for Enterprise and Industry; the Ministry of 
Health, Labor and Welfare of Japan; and the U.S. Food and Drug 
Administration. All decisions made by consensus will be compatible with 
the laws, policies, rules, regulations, and directives of the 
respective administrations and governments. Members will implement and/
or promote actions or documents within their own jurisdictions and seek 
convergence of regulatory policies and practices. Successful 
implementation will require input from stakeholders.
    Interested persons may present data, information, or views orally 
or in writing, on issues pending at the public meeting. Time allotted 
for oral presentations may be limited to 10 minutes. Those desiring to 
make oral presentations should notify the contact person by April 22, 
2011, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses, 
telephone number, fax, and email of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    The agenda for the public meeting will be made available on the 
Internet at http://www.fda.gov/Cosmetics/InternationalActivities/ConferencesMeetingsWorkshops/InternationalCooperationonCosmeticsRegulationsICCR/default.htm.

    Dated: March 6, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012-5744 Filed 3-8-12; 8:45 am]
BILLING CODE 4160-01-P